Genelux (GNLX) Cash from Investing Activities (2022 - 2026)

Genelux's (GNLX) quarterly Cash from Investing Activities came in at -$8.5 million in Q1 2026, down 343.35% year-on-year from $3.5 million in Q1 2025, and down 230.09% quarter-over-quarter from $6.6 million in Q4 2025.

Genelux (GNLX) Cash from Investing Activities (2022 - 2026) Analysis & Trends

Genelux's Cash from Investing Activities history runs 5 years deep, the most recent figure standing at -$8.5 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 343.35% year-over-year to -$8.5 million in Q1 2026; TTM through Mar 2026 was $93000.0, a 103.17% increase from a year earlier, with the FY2025 full-year figure at $12.1 million, up 249.32% from the prior year.
  • Cash from Investing Activities fell to -$8.5 million in Q1 2026 per GNLX's latest filing, from $6.6 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $6.7 million in Q4 2024 and bottomed at -$17.1 million in Q2 2024.
  • The 5-year median for Cash from Investing Activities is -$193000.0 (2023), against an average of -$1.4 million.
  • Biggest YoY gain for Cash from Investing Activities was 1541.16% in 2024; the steepest drop was 4219.7% in 2024.
  • Year by year, Cash from Investing Activities stood at -$15000.0 in 2022, then plunged by 92846.67% to -$13.9 million in 2023, then surged by 147.87% to $6.7 million in 2024, then slipped by 1.65% to $6.6 million in 2025, then tumbled by 230.09% to -$8.5 million in 2026.
  • Per Business Quant, the three latest GNLX Cash from Investing Activities figures stand at -$8.5 million (Q1 2026), $6.6 million (Q4 2025), and $4.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 172.62 Mn
10 Genelux 129.36 Mn 129.36 Mn - -8.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.54 Mn
Mar 31, 2026 -8.54 Mn
Dec 31, 2025 6.56 Mn
Dec 31, 2025 6.56 Mn
Sep 30, 2025 4.72 Mn
Sep 30, 2025 4.72 Mn
Jun 30, 2025 -2.65 Mn
Jun 30, 2025 -2.65 Mn
Mar 31, 2025 3.51 Mn
Mar 31, 2025 3.51 Mn
Dec 31, 2024 6.67 Mn
Dec 31, 2024 6.67 Mn
Sep 30, 2024 3.99 Mn
Sep 30, 2024 3.99 Mn
Jun 30, 2024 -17.11 Mn
Jun 30, 2024 -17.11 Mn
Mar 31, 2024 -1.69 Mn
Mar 31, 2024 -1.69 Mn
Dec 31, 2023 -13.94 Mn
Dec 31, 2023 -13.94 Mn